{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-020292","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2024-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.760802+00:00","generated_at":"2026-06-01T21:41:46.776245+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"PowerUp Acquisition postpones extraordinary general meeting to May 21; shareholders to vote on extension to Feb 2025","bullets":["Meeting postponed from May 17 to May 21, 2024 at 9:00 a.m. ET.","Shareholders will vote on extending business combination deadline from May 23, 2024 to February 17, 2025.","Redemption deadline extended to May 17, 2024; shareholders can withdraw previously submitted requests.","No changes to record date, location, or proposals to be voted on."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-020292","json":"https://secwatch.observer/filing/0001493152-24-020292.json","markdown":"https://secwatch.observer/filing/0001493152-24-020292.md","text":"https://secwatch.observer/filing/0001493152-24-020292.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315224020292/0001493152-24-020292-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315224020292/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T21:41:46.776245+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}